Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease
ConditionParkinson Disease
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-85
SponsorProgenaBiome
About this trial
FMT may significantly improve quality of life and Parkinson Disease (PD) symptom severity measurements. We hypothesize that gut microbial dysbiosis is a major contributing factor in Parkinson's disease.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Individuals diagnosed with PD
Disqualifiers
Non-PD individuals
Trial design
Design model
Single group
Treatments tested in this trial
Fecal Microbiota Transplant
Combination productFecal Microbiota Transplant
Treatment groups
10 Participants
are divided into 1 treatment groupGroup A: PD patientsOther 1 intervention
Trial outcomes
Primary outcomes
1
Parkinson's disease symptoms
Changes in symptoms reported
Time frame
6.5 months for each subjectSecondary outcomes
1
Alterations in Subject microbiome from baseline
Changes in microbiome Shannon Diversity Index and relative abundance
Time frame
6.5 months for each subjectSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: